We are live on
!
Find out more
DMTX
Dimension Therapeutics, Inc
DMTX
DMTX
Delisted
DMTX was delisted on the 6th of November, 2017.
35 hedge funds and large institutions have $25.7M invested in Dimension Therapeutics, Inc in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $32.7M → $25.7M (-$6.96M)
26% less funds holding
Funds holding: 47 → 35 (-12)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
Holders
35
Holders Change
-12
Holders Change %
-25.53%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
16
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$115K |
| 2 |
Renaissance Technologies
New York
|
+$84.8K |
| 3 |
ECM
Element Capital Management
New York
|
+$84.6K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$74.8K |
| 5 |
Goldman Sachs
New York
|
+$73.7K |
Top Sellers
| 1 |
BlackRock
New York
|
-$674K |
| 2 |
State Street
Boston,
Massachusetts
|
-$231K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$213K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$141K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$108K |
